
Your Partner for Vaccine Clinical Trial Management
How we help vaccine clinical trials succeed
- Patient Recruitment
- Patient Management
- Data Collection
- Regulatory Compliance
Patient Recruitment
Patient Recruitment
With an extensive pre-screened patient database and an exceptional 35% diversity rate, we’ve helped sponsors and CROs meet enrollment targets for vaccine trials—bringing creative recruitment strategies to the table to meet even the tightest of timelines. Once we identify participants who best align with study criteria, we engage and onboard them quickly to keep trials on schedule and within budget.Patient Management
Patient Management
We strive to make patients feel valued and supported at every stage of your trial—and it shows. Regular communications with patients keep them informed and engaged, while minimizing their wait times during site visits. Flexible scheduling, free transportation services, and at-home delivery options further support our 98% patient retention rate.Data Collection
Data Collection
Information gathered from patients during a vaccine trial is entered into our electronic data capture system the same day for real-time visibility, with any discrepancies automatically flagged. For trials that allow for more flexibility, our team has extensive experience in decentralized methodologies—and we’ve even helped pivot trials to this model.Regulatory Compliance
Regulatory Compliance
From initiation to close-out, we employ proactive strategies to keep vaccine trials compliant. Our team closely monitors trial operations and data quality at every stage to ensure timely submissions, proper progress reporting, and adherence to Good Clinical Practice standards.Highlights from our extensive vaccine trial experience
E. Coli Vaccine in Adults with Chronic UTI
- Phase II placebo-controlled trial
- 66 randomized patients
Norovirus Vaccine in Healthy Adults
- Phase III placebo-controlled trial
- Screened 86 patients; randomized 83
Botulism Vaccine for Production of Botulism Immunoglobin
- Partnered with defense contractor
- 3 studies with total enrollment of 57 subjects
Staphylococcus Aureus Vaccine in Adults Undergoing Elective Spinal Fusion
- Partnered with orthopedic center to enroll subjects
- Screened 49 patients; randomized 47
- Exceeded study goal of 25 participants
Clostridium Difficile Vaccine in Adults 50 and Older
- Partnered with community hospital
- Screened 45 patients; randomized 44
- Exceeded study goal of 20 participants
Interested in participating in a study?
Discover the latest RDI studies that are currently enrolling, learn more about their focus, and find out how you can participate in groundbreaking research.
Trial management expertise in a patient-centric environment
At Remington-Davis, we’re committed to creating positive patient experiences. Our 7,500 square-foot facility in Columbus, Ohio is a reflection of that.
RDI’s modern facility features a home-like environment that includes Wi-Fi, beverages, food, and other comforts to support a positive experience. When appointments are long, meals are provided at no cost. When there are prolonged wait periods, we offer study participants a private space that’s complete with reclining chairs and other comforts.
Our goal is to make participants feel cared for from the moment they arrive at our site to the moment your trial is complete.
What industry professionals have to say about working with RDI
Partner with us for your next vaccine trial.
At Remington-Davis Clinical Research, we are committed to supporting you with trusted clinical research services. Schedule a 30-minute consultation with us to discuss your clinical trial management challenges and learn how we can help.